U.S. markets closed

PT Kalbe Farma Tbk. (PTKFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.10500.0000 (0.00%)
At close: 9:41AM EST

PT Kalbe Farma Tbk.

Gedung KALBE
Jl. Let. Jend Suprapto Kav 4
Jakarta 10510
62 21 4287 3888

IndustryDrug Manufacturers—General
Full Time Employees12,161

Key Executives

NameTitlePayExercisedYear Born
Mr. - VidjongtiusPres DirectorN/AN/A1964
Mr. Lukito GozaliHead of Investor RelationsN/AN/AN/A
Ms. Lanny SoputroDirector of HR, Gen. Affairs & HSSEN/AN/A1964
Mr. Kurniawan SuhartonoHead of Internal Audit UnitN/AN/A1965
Mr. Sie DjohanDirector of Corp. Bus. Devel., Management System & Regulatory Affairs and DirectorN/AN/A1967
Mr. Bernadus Karmin WinataIndependent Director & Corp. Sec.N/AN/A1964
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. It operates in four division: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The company offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. It also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, pre-teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, the company operates Mitrasana Clinics, a health care service; contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products. Further, it offers health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as provides advertising services. The company was founded in 1966 and is headquartered in Jakarta, Indonesia. PT Kalbe Farma Tbk. is a subsidiary of PT Gira Sole Prima.

Corporate Governance

PT Kalbe Farma Tbk.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.